Methazolamide 25 MG Oral Tablet — RxCUI 197939
RxNorm drug concept · Semantic clinical drug
RxCUI 197939
Semantic clinical drug · SCD
● Current RxNorm concept 18 FDA products
28 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI197939
Official nameMethazolamide 25 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped18
Package NDCs mapped28
Reported Medicaid activity (SDUD)4,047 prescriptions · 21 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Methazolamide: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's reducing the pressure inside your eye. Your eye constantly makes a fluid called aqueous humor, and methazolamide slows down how much of that fluid is produced. Less fluid mean...
- What is methazolamide actually doing for my eyes?
- The most common one people notice is a tingling or 'pins and needles' feeling in their hands and feet — it can be a little odd but it's well known with this type of drug. You might...
- What side effects should I actually expect when I start taking it?
🕸️ Concept Web — How Methazolamide 25 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Methazolamide 25 MG Oral Tablet
RxCUI 197939 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Methazolamide
6826IN
-
Methazolamide
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Methazolamide Oral Tablet
372815SCDF -
Methazolamide Oral Product
1161639SCDG -
Methazolamide Pill
1162202SCDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Methazolamide Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Methazolamide 25 MG
316261SCDC
-
Methazolamide 25 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Methazolamide 25 MG
SCDC · 316261 -
Methazolamide Oral Tablet
SCDF · 372815 -
Methazolamide Oral Product
SCDG · 1161639 -
Methazolamide Pill
SCDG · 1162202
📦 FDA Products & Package NDCs
18 products · 28 package NDCs
28 package NDCs map to RxCUI 197939 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00574-0790-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0574-0790-01) | methazolamide | Padagis US LLC | 2014-09-30 |
| 00574-0791-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0574-0791-01) | methazolamide | Padagis US LLC | 2014-09-30 |
| 24208-0022-01 | 1000 TABLET in 1 BOTTLE (24208-022-01) | Methazolamide | Bausch & Lomb Incorporated | 2020-10-02 |
| 24208-0022-10 | 100 TABLET in 1 BOTTLE (24208-022-10) | Methazolamide | Bausch & Lomb Incorporated | 2020-10-02 |
| 24208-0022-50 | 500 TABLET in 1 BOTTLE (24208-022-50) | Methazolamide | Bausch & Lomb Incorporated | 2020-10-02 |
| 24208-0022-90 | 90 TABLET in 1 BOTTLE (24208-022-90) | Methazolamide | Bausch & Lomb Incorporated | 2020-10-02 |
| 24208-0023-01 | 1000 TABLET in 1 BOTTLE (24208-023-01) | Methazolamide | Bausch & Lomb Incorporated | 2020-10-02 |
| 24208-0023-10 | 100 TABLET in 1 BOTTLE (24208-023-10) | Methazolamide | Bausch & Lomb Incorporated | 2020-10-02 |
| 24208-0023-50 | 500 TABLET in 1 BOTTLE (24208-023-50) | Methazolamide | Bausch & Lomb Incorporated | 2020-10-02 |
| 24208-0023-90 | 90 TABLET in 1 BOTTLE (24208-023-90) | Methazolamide | Bausch & Lomb Incorporated | 2020-10-02 |
| 27241-0246-01 | 100 TABLET in 1 BOTTLE (27241-246-01) | Methazolamide | Ajanta Pharma USA Inc. | 2026-02-09 |
| 27241-0247-01 | 100 TABLET in 1 BOTTLE (27241-247-01) | Methazolamide | Ajanta Pharma USA Inc. | 2026-02-09 |
| 42571-0239-05 | 500 TABLET in 1 BOTTLE (42571-239-05) | METHAZOLAMIDE | Micro Labs Limited | 2019-03-05 |
| 42571-0239-10 | 1000 TABLET in 1 BOTTLE (42571-239-10) | METHAZOLAMIDE | Micro Labs Limited | 2019-03-05 |
| 42571-0239-90 | 90 TABLET in 1 BOTTLE (42571-239-90) | METHAZOLAMIDE | Micro Labs Limited | 2019-03-05 |
| 42571-0240-05 | 500 TABLET in 1 BOTTLE (42571-240-05) | METHAZOLAMIDE | Micro Labs Limited | 2019-03-05 |
| 42571-0240-10 | 1000 TABLET in 1 BOTTLE (42571-240-10) | METHAZOLAMIDE | Micro Labs Limited | 2019-03-05 |
| 42571-0240-90 | 90 TABLET in 1 BOTTLE (42571-240-90) | METHAZOLAMIDE | Micro Labs Limited | 2019-03-05 |
| 51407-0026-01 | 100 TABLET in 1 BOTTLE (51407-026-01) | Methazolamide | Golden State Medical Supply, Inc. | 2018-01-01 |
| 51407-0027-01 | 100 TABLET in 1 BOTTLE (51407-027-01) | Methazolamide | Golden State Medical Supply, Inc. | 2018-01-01 |
| 62559-0240-01 | 100 TABLET in 1 BOTTLE (62559-240-01) | Methazolamide | ANI Pharmaceuticals, Inc. | 2014-11-06 |
| 62559-0241-01 | 100 TABLET in 1 BOTTLE (62559-241-01) | Methazolamide | ANI Pharmaceuticals, Inc. | 2014-11-06 |
| 63629-1986-01 | 100 TABLET in 1 BOTTLE (63629-1986-1) | Methazolamide | Bryant Ranch Prepack | 2021-01-15 |
| 68094-0808-50 | 100 TABLET in 1 BOTTLE (68094-808-50) | Methazolamide | Precision Dose, Inc. | 2023-11-30 |
| 68094-0908-50 | 100 TABLET in 1 BOTTLE (68094-908-50) | Methazolamide | Precision Dose, Inc. | 2023-11-30 |
| 72162-1754-01 | 100 TABLET in 1 BOTTLE (72162-1754-1) | Methazolamide | Bryant Ranch Prepack | 2026-03-25 |
| 72603-0166-01 | 100 TABLET in 1 BOTTLE (72603-166-01) | Methazolamide | NorthStar Rx LLC | 2023-08-30 |
| 72603-0167-01 | 100 TABLET in 1 BOTTLE (72603-167-01) | Methazolamide | NorthStar Rx LLC | 2023-08-30 |
Observed labelers:
Bausch & Lomb Incorporated (8) ·
Micro Labs Limited (6) ·
Ajanta Pharma USA Inc. (2) ·
ANI Pharmaceuticals, Inc. (2) ·
Bryant Ranch Prepack (2) ·
Golden State Medical Supply, Inc. (2)
· +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.